SCHEMBL4481470

SCHEMBL4481470

B.CSSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL99 0.91
SCHEMBL10614835 0.91
SCHEMBL31538690 0.83
SCHEMBL10882479 0.83
SCHEMBL28322312 0.83
SCHEMBL8092473 0.83
SCHEMBL31491199 0.83
Methylsulfanylmethane SCHEMBL9772132 0.83
Ammonia Solution, Strong SCHEMBL22747857 0.83
SCHEMBL27951421 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102395445-A Device and method for simultaneously microstructuring and doping semiconductor substrates FRAUNHOFER GES FORSCHUNG 2012-03-28 CN claimed
CN-107108460-B Method for producing diamine precursor compound 日产化学工业株式会社 2019-10-22 CN disclosed
CN-105061454-B Method for producing alcohol compound, and method for producing (meth) acrylate 三菱化学株式会社 2019-09-27 CN disclosed
CN-109963833-A It is used to prepare mono-protected α, ω-Diaminoalkane method 斯索恩生物制药有限公司 2019-07-02 CN disclosed
CN-109843291-A synthetic retinoids (cell modulation) 杜伦大学 2019-06-04 CN disclosed
CN-109790125-A TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS 研究三角协会 2019-05-21 CN disclosed
CN-108699575-A Method for generating 3- hydroxypropanamides using Luo Wang acetobacters 绿色生物制品有限公司 2018-10-23 CN disclosed
CN-108601788-A EIF 4A-inhibiting compounds and methods relating thereto 效应治疗股份有限公司 2018-09-28 CN disclosed
CN-105916856-B Substituted 4,5,6,7- tetrahydro-pyrazoles as Casein kinase 1 D/E inhibitor simultaneously [1,5-A] pyrazines derivatives 百时美施贵宝公司 2018-09-25 CN disclosed
CN-108495836-A N-butanal single stage is converted to 2- ethyl hexanals 伊士曼化工公司 2018-09-04 CN disclosed
US-5538969-A IMMUNOSUPPRESSANTS SYNTEX (U.S.A.) INC. (US) 1996-07-23 US disclosed
US-5536747-A ENZYME INHIBITORS SYNTEX (U.S.A.) INC. (US) 1996-07-16 US disclosed
US-5525602-A TREATING INFLAMMATORY DISEASES, PREVENTING ALLOGRAFT REJECTION, AUTOIMMUNE DISEASES SYNTEX (U.S.A.) INC. (US) 1996-06-11 US disclosed
US-5512568-A FOR TREATING A MAMMAL HAVING A DISEASE STATE THAT IS ALLEVIATED BY TREATMENT WITH AN INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE INHIBITOR SYNTEX (U.S.A.) INC. (US) 1996-04-30 US disclosed
US-5493030-A CHEMICAL INTERMEDIATES SYNTEX (U.S.A.) INC. (US) 1996-02-20 US disclosed
WO-1995022534-A1 4-AMINO 6-SUBSTITUTED MYCOPHENOLIC ACID AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY SYNTEX (U.S.A.) INC. (US) 1995-08-24 WO disclosed
WO-1995022538-A1 5-SUBSTITUTED DERIVATIVES OF MYCOPHENOLIC ACID SYNTEX (U.S.A.) INC. (US) 1995-08-24 WO disclosed
WO-1995022537-A2 4-AMINO DERIVATIVES OF 5-SUBSTITUTED MYCOPHENOLIC ACID SYNTEX (U.S.A.) INC. (US) 1995-08-24 WO disclosed
WO-1995022536-A1 6-SUBSTITUTED MYCOPHENOLIC AND DERIVATIVES WITH IMMUNOSUPPRESSIVE ACTIVITY SYNTEX (U.S.A.) INC. (US) 1995-08-24 WO disclosed
US-5444072-A Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis SYNTEX (U.S.A.) INC. (US) 1995-08-22 US disclosed